Related Experiment Video
Updated: May 23, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure
Phillip J Newton1, Patricia M Davidson, Henry Krum
1Centre for Cardiovascular and Chronic Care, Faculty of Nursing, Midwifery & Health, University of Technology Sydney, Australia. phillip.newton@uts.edu.au
Purpose:
To assess the acute haemodynamic effects of nebulised frusemide in a stable advanced heart failure population.
Procedure:
In this randomised, double blind, placebo controlled trial, people with stable, advanced heart failure undergoing right heart catheterisation were randomised to receive either 40 mg (4 ml) of nebulised frusemide or 4 ml of normal saline. Following inhalation of the study medication, subjects' pulmonary pressures were recorded every 15 min for 1 h.
Findings:
There were no significant changes in the weighted average time course data of the subjects (n=32) in either group over the study period, in particular no differences were observed in haemodynamic parameters between the two groups. Weighted average pulmonary capillary wedge pressure after 60 min in the frusemide group was 22.5 (SD 6.5) mmHg (n=14) compared to the placebo group's 24.0 (SD 7.3) mmHg (n=18), p=0.55. The frusemide group had a significantly greater change in the median volume of urine in the bladder over the study period (186 ml IQR 137.8-260.8) compared to the placebo group (76 ml IQR 39.0-148.0) p=0.02.
Conclusion:
This study showed that nebulised frusemide had no significant clinical effect on the haemodynamic characteristics of the subjects.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Heart Failure Drugs: Diuretics
Heart Failure VI: Adjunct Therapies
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...